AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib <i>versus</i> letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer - Concepedia

Concepedia

Publication | Open Access

AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib <i>versus</i> letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer

DOI Full Paper Access

28

Citations

27

References

2022

Year

Aditya Bardia, Javier Cortés, Sara A. Hurvitz, Suzette Delaloge, Hiroji Iwata, Zhi‐Ming Shao, Dheepak Kanagavel, Patrick Cohen, Qianying Liu, Sylvaine Cartot‐Cotton,

Therapeutic Advances in Medical Oncology

Abstract

NCT04478266.

References

	Year	Citations

Page 1